Literature DB >> 29449511

CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.

Janice S Chen1, Enbo Ma1, Lucas B Harrington1, Maria Da Costa2, Xinran Tian3, Joel M Palefsky2, Jennifer A Doudna4,3,5,6,7.   

Abstract

CRISPR-Cas12a (Cpf1) proteins are RNA-guided enzymes that bind and cut DNA as components of bacterial adaptive immune systems. Like CRISPR-Cas9, Cas12a has been harnessed for genome editing on the basis of its ability to generate targeted, double-stranded DNA breaks. Here we show that RNA-guided DNA binding unleashes indiscriminate single-stranded DNA (ssDNA) cleavage activity by Cas12a that completely degrades ssDNA molecules. We find that target-activated, nonspecific single-stranded deoxyribonuclease (ssDNase) cleavage is also a property of other type V CRISPR-Cas12 enzymes. By combining Cas12a ssDNase activation with isothermal amplification, we create a method termed DNA endonuclease-targeted CRISPR trans reporter (DETECTR), which achieves attomolar sensitivity for DNA detection. DETECTR enables rapid and specific detection of human papillomavirus in patient samples, thereby providing a simple platform for molecular diagnostics.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29449511      PMCID: PMC6628903          DOI: 10.1126/science.aar6245

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  36 in total

1.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

Review 2.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

Review 3.  The natural history of cervical HPV infection: unresolved issues.

Authors:  Ciaran B J Woodman; Stuart I Collins; Lawrence S Young
Journal:  Nat Rev Cancer       Date:  2007-01       Impact factor: 60.716

4.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

5.  Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.

Authors:  William T Seaman; Elizabeth Andrews; Marion Couch; Erna M Kojic; Susan Cu-Uvin; Joel Palefsky; Allison M Deal; Jennifer Webster-Cyriaque
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

6.  Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects.

Authors:  José M Sogo; Massimo Lopes; Marco Foiani
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

7.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

8.  Structural basis of transcription initiation.

Authors:  Yu Zhang; Yu Feng; Sujoy Chatterjee; Steve Tuske; Mary X Ho; Eddy Arnold; Richard H Ebright
Journal:  Science       Date:  2012-10-18       Impact factor: 47.728

9.  Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity.

Authors:  Poulami Samai; Nora Pyenson; Wenyan Jiang; Gregory W Goldberg; Asma Hatoum-Aslan; Luciano A Marraffini
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

10.  DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.

Authors:  Samuel H Sternberg; Sy Redding; Martin Jinek; Eric C Greene; Jennifer A Doudna
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

View more
  490 in total

Review 1.  CRISPR-Cas9 Probing of Infectious Diseases and Genetic Disorders.

Authors:  Sivaprakash Ramalingam; Saravanabhavan Thangavel
Journal:  Indian J Pediatr       Date:  2019-07-31       Impact factor: 1.967

2.  Faster, better, cheaper: the rise of CRISPR in disease detection.

Authors:  Amy Maxmen
Journal:  Nature       Date:  2019-02       Impact factor: 49.962

3.  Mammoth, Arbor and Beam launch new wave of CRISPR startups.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2018-06-06       Impact factor: 54.908

4.  Inconclusive studies on possible CRISPR-Cas off-targets should moderate expectations about enzymes that have evolved to be non-specific.

Authors:  Sandeep Chakraborty
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

5.  A Highly Productive, One-Pot Cell-Free Protein Synthesis Platform Based on Genomically Recoded Escherichia coli.

Authors:  Benjamin J Des Soye; Vincent R Gerbasi; Paul M Thomas; Neil L Kelleher; Michael C Jewett
Journal:  Cell Chem Biol       Date:  2019-11-06       Impact factor: 8.116

6.  Reprogrammable Gel Electrophoresis Detection Assay Using CRISPR-Cas12a and Hybridization Chain Reaction.

Authors:  Mahera J Kachwala; Christopher W Smith; Nidhi Nandu; Mehmet V Yigit
Journal:  Anal Chem       Date:  2021-01-06       Impact factor: 6.986

Review 7.  Exploring the Trans-Cleavage Activity of CRISPR-Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor.

Authors:  Yifan Dai; Rodrigo A Somoza; Liu Wang; Jean F Welter; Yan Li; Arnold I Caplan; Chung Chiun Liu
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-17       Impact factor: 15.336

8.  Identification of Mycobacterium abscessus species and subspecies using the Cas12a/sgRNA-based nucleic acid detection platform.

Authors:  Guohui Xiao; Su Zhang; Zhihang Liang; Guanqiang Li; Mutong Fang; Yaya Liu; Juanjuan Zhang; Min Ou; Xing He; Tianyu Zhang; Changchun Zeng; Lei Liu; Guoliang Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-28       Impact factor: 3.267

9.  Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.

Authors:  Tong Guo; Fan Zheng; Zhifeng Zeng; Yang Yang; Qi Li; Qunxin She; Wenyuan Han
Journal:  RNA Biol       Date:  2019-07-17       Impact factor: 4.652

10.  PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage.

Authors:  Tautvydas Karvelis; Greta Bigelyte; Joshua K Young; Zhenglin Hou; Rimante Zedaveinyte; Karolina Budre; Sushmitha Paulraj; Vesna Djukanovic; Stephen Gasior; Arunas Silanskas; Česlovas Venclovas; Virginijus Siksnys
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.